Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30

$0.88−0.03 (-3.52%)

Close on Nov 13, 2026Market cap $7.06MP/E –Yield –

Immuron total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Immuron's total debt was A$139.86K at Jun 30, 2017. For fiscal 2017 it was A$139.86K.

Period	Period end	Value	Change
FY2017	Jun 30, 2017	A$139.86K	–

Change is against the same quarter a year earlier.

Periods

Period	Period end	Value	Change
Q4 FY2017CQ2 2017	Jun 30, 2017	A$139.86K	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMRN.

Revenue growth5.9% · median 3.4%

Operating margin-49.9% · median -530.5%

Net margin-47.7% · median -493.0%

Advertisement
300 × 250

See a number that looks wrong?